• 1
    Blanpain C, Horsley V & Fuchs E (2007) Epithelial stem cells: turning over new leaves. Cell128, 445458.
  • 2
    Orkin SH & Zon LI (2008) Hematopoiesis: an evolving paradigm for stem cell biology. Cell132, 631644.
  • 3
    Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA & Dick JE (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature367, 645648.
  • 4
    Huntly BJ & Gilliland DG (2004) Blasts from the past: new lessons in stem cell biology from chronic myelogenous leukemia. Cancer Cell6, 199201.
  • 5
    Krivtsov AV, Twomey D, Feng Z, Stubbs MC, Wang Y, Faber J, Levine JE, Wang J, Hahn WC, Gilliland DG et al. (2006) Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature442, 818822.
  • 6
    Zhang M, Behbod F, Atkinson RL, Landis MD, Kittrell F, Edwards D, Medina D, Tsimelzon A, Hilsenbeck S, Green JE et al. (2008) Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Res68, 46744682.
  • 7
    Dick JE (2008) Stem cell concepts renew cancer research. Blood112, 47934807.
  • 8
    Shackleton M, Quintana E, Fearon ER & Morrison SJ (2009) Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell138, 822829.
  • 9
    Bruce WR & Van Der Gaag H (1963) A quantitative assay for the number of murine lymphoma cells capable of proliferation in vivo. Nature199, 7980.
  • 10
    Reya T, Morrison SJ, Clarke MF & Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature414, 105111.
  • 11
    Blanpain C & Fuchs E (2009) Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol10, 207217.
  • 12
    Luo J, Yin X, Ma T & Lu J (2010) Stem cells in normal mammary gland and breast cancer. Am J Med Sci339, 366370.
  • 13
    van der Flier LG & Clevers H (2009) Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol71, 241260.
  • 14
    Cicalese A, Bonizzi G, Pasi CE, Faretta M, Ronzoni S, Giulini B, Brisken C, Minucci S, Di Fiore PP & Pelicci PG (2009) The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell138, 10831095.
  • 15
    Liu Y, Elf SE, Miyata Y, Sashida G, Huang G, Di Giandomenico S, Lee JM, Deblasio A, Menendez S, Antipin J et al. (2009) p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell4, 3748.
  • 16
    Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF & Morrison SJ (2003) Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature425, 962967.
  • 17
    Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, Morrison SJ & Clarke MF (2003) Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature423, 302305.
  • 18
    Matsumoto A, Takeishi S, Kanie T, Susaki E, Onoyama I, Tateishi Y, Nakayama K & Nakayama KI (2011) p57 is required for quiescence and maintenance of adult hematopoietic stem cells. Cell Stem Cell9, 262271.
  • 19
    Zou P, Yoshihara H, Hosokawa K, Tai I, Shinmyozu K, Tsukahara F, Maru Y, Nakayama K, Nakayama KI & Suda T (2011) p57(Kip2) and p27(Kip1) cooperate to maintain hematopoietic stem cell quiescence through interactions with Hsc70. Cell Stem Cell9, 247261.
  • 20
    Cheng T, Rodrigues N, Dombkowski D, Stier S & Scadden DT (2000) Stem cell repopulation efficiency but not pool size is governed by p27(kip1). Nat Med6, 12351240.
  • 21
    Cheng T, Rodrigues N, Shen H, Yang Y, Dombkowski D, Sykes M & Scadden DT (2000) Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science287, 18041808.
  • 22
    Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM & Morrison SJ (2008) Efficient tumour formation by single human melanoma cells. Nature456, 593598.
  • 23
    Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD & Dirks PB (2004) Identification of human brain tumour initiating cells. Nature432, 396401.
  • 24
    Bonnet D & Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med3, 730737.
  • 25
    Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ & Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA100, 39833988.
  • 26
    Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C & De Maria R (2007) Identification and expansion of human colon-cancer-initiating cells. Nature445, 111115.
  • 27
    Pece S, Tosoni D, Confalonieri S, Mazzarol G, Vecchi M, Ronzoni S, Bernard L, Viale G, Pelicci PG & Di Fiore PP (2010) Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell140, 6273.
  • 28
    Miyamoto T, Weissman IL & Akashi K (2000) AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc Natl Acad Sci USA97, 75217526.
  • 29
    Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J & Dirks PB (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res63, 58215828.
  • 30
    Collins AT, Berry PA, Hyde C, Stower MJ & Maitland NJ (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res65, 1094610951.
  • 31
    Wang Z, Smith KS, Murphy M, Piloto O, Somervaille TC & Cleary ML (2008) Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy. Nature455, 12051209.
  • 32
    Traver D, Akashi K, Weissman IL & Lagasse E (1998) Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia. Immunity9, 4757.
  • 33
    Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, Asselin-Labat ML, Gyorki DE, Ward T, Partanen A et al. (2009) Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med15, 907913.
  • 34
    Chaffer CL, Brueckmann I, Scheel C, Kaestli AJ, Wiggins PA, Rodrigues LO, Brooks M, Reinhardt F, Su Y, Polyak K et al. (2011) Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci USA108, 79507955.
  • 35
    McCulloch EA, Siminovitch L & Till JE (1964) Spleen-colony formation in anemic mice of genotype Ww. Science144, 844846.
  • 36
    McCulloch EA, Siminovitch L, Till JE, Russell ES & Bernstein SE (1965) The cellular basis of the genetically determined hemopoietic defect in anemic mice of genotype Sl-Sld. Blood26, 399410.
  • 37
    Till JE & McCulloch EA (1961) A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res14, 213222.
  • 38
    Seita J & Weissman IL (2010) Hematopoietic stem cell: self-renewal versus differentiation. Wiley Interdiscip Rev Syst Biol Med2, 640653.
  • 39
    Spangrude GJ, Heimfeld S & Weissman IL (1988) Purification and characterization of mouse hematopoietic stem cells. Science241, 5862.
  • 40
    Ikuta K & Weissman IL (1992) Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc Natl Acad Sci USA89, 15021506.
  • 41
    Osawa M, Hanada K, Hamada H & Nakauchi H (1996) Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science273, 242245.
  • 42
    Christensen JL & Weissman IL (2001) Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc Natl Acad Sci USA98, 1454114546.
  • 43
    Wagers AJ, Sherwood RI, Christensen JL & Weissman IL (2002) Little evidence for developmental plasticity of adult hematopoietic stem cells. Science297, 22562259.
  • 44
    Adolfsson J, Mansson R, Buza-Vidas N, Hultquist A, Liuba K, Jensen CT, Bryder D, Yang L, Borge OJ, Thoren LA et al. (2005) Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell121, 295306.
  • 45
    Kiel MJ, Yilmaz OH, Iwashita T, Terhorst C & Morrison SJ (2005) SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell121, 11091121.
  • 46
    Neering SJ, Bushnell T, Sozer S, Ashton J, Rossi RM, Wang PY, Bell DR, Heinrich D, Bottaro A & Jordan CT (2007) Leukemia stem cells in a genetically defined murine model of blast-crisis CML. Blood110, 25782585.
  • 47
    Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL, Gotlib J, Li K, Manz MG, Keating A et al. (2004) Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med351, 657667.
  • 48
    Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D, Li HI & Eaves CJ (2006) Purification and unique properties of mammary epithelial stem cells. Nature439, 993997.
  • 49
    Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ & Visvader JE (2006) Generation of a functional mammary gland from a single stem cell. Nature439, 8488.
  • 50
    Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S et al. (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell1, 555567.
  • 51
    Spangrude GJ, Brooks DM & Tumas DB (1995) Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: in vivo expansion of stem cell phenotype but not function. Blood85, 10061016.
  • 52
    Holyoake T, Jiang X, Eaves C & Eaves A (1999) Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood94, 20562064.
  • 53
    Guan Y, Ralph S & Hogge DE (2002) Polyclonal normal hematopoietic progenitors in patients with acute myeloid leukemia. Exp Hematol30, 721728.
  • 54
    Tumbar T, Guasch G, Greco V, Blanpain C, Lowry WE, Rendl M & Fuchs E (2004) Defining the epithelial stem cell niche in skin. Science303, 359363.
  • 55
    Wilson A, Laurenti E, Oser G, van der Wath RC, Blanco-Bose W, Jaworski M, Offner S, Dunant CF, Eshkind L, Bockamp E et al. (2008) Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell135, 11181129.
  • 56
    Welm BE, Tepera SB, Venezia T, Graubert TA, Rosen JM & Goodell MA (2002) Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev Biol245, 4256.
  • 57
    Alvi AJ, Clayton H, Joshi C, Enver T, Ashworth A, Vivanco MM, Dale TC & Smalley MJ (2003) Functional and molecular characterisation of mammary side population cells. Breast Cancer Res5, R1R8.
  • 58
    Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ & Wicha MS (2003) In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev17, 12531270.
  • 59
    Kordon EC & Smith GH (1998) An entire functional mammary gland may comprise the progeny from a single cell. Development125, 19211930.
  • 60
    Knoblich JA (2010) Asymmetric cell division: recent developments and their implications for tumour biology. Nat Rev Mol Cell Biol11, 849860.
  • 61
    Lechler T & Fuchs E (2005) Asymmetric cell divisions promote stratification and differentiation of mammalian skin. Nature437, 275280.
  • 62
    Quyn AJ, Appleton PL, Carey FA, Steele RJ, Barker N, Clevers H, Ridgway RA, Sansom OJ & Nathke IS (2010) Spindle orientation bias in gut epithelial stem cell compartments is lost in precancerous tissue. Cell Stem Cell6, 175181.
  • 63
    Shinin V, Gayraud-Morel B, Gomes D & Tajbakhsh S (2006) Asymmetric division and cosegregation of template DNA strands in adult muscle satellite cells. Nat Cell Biol8, 677687.
  • 64
    Wu M, Kwon HY, Rattis F, Blum J, Zhao C, Ashkenazi R, Jackson TL, Gaiano N, Oliver T & Reya T (2007) Imaging hematopoietic precursor division in real time. Cell Stem Cell1, 541554.
  • 65
    Castellanos E, Dominguez P & Gonzalez C (2008) Centrosome dysfunction in Drosophila neural stem cells causes tumors that are not due to genome instability. Curr Biol18, 12091214.
  • 66
    Egger B, Gold KS & Brand AH (2010) Notch regulates the switch from symmetric to asymmetric neural stem cell division in the Drosophila optic lobe. Development137, 29812987.
  • 67
    Pece S, Serresi M, Santolini E, Capra M, Hulleman E, Galimberti V, Zurrida S, Maisonneuve P, Viale G & Di Fiore PP (2004) Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol167, 215221.
  • 68
    Schimanski CC, Schmitz G, Kashyap A, Bosserhoff AK, Bataille F, Schafer SC, Lehr HA, Berger MR, Galle PR, Strand S et al. (2005) Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancer. Oncogene24, 31003109.
  • 69
    Glazer RI, Vo DT & Penalva LO (2012) Musashi1: an RBP with versatile functions in normal and cancer stem cells. Front Biosci17, 5464.
  • 70
    Wilson A, Murphy MJ, Oskarsson T, Kaloulis K, Bettess MD, Oser GM, Pasche AC, Knabenhans C, Macdonald HR & Trumpp A (2004) c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev18, 27472763.
  • 71
    Laurenti E, Varnum-Finney B, Wilson A, Ferrero I, Blanco-Bose WE, Ehninger A, Knoepfler PS, Cheng PF, MacDonald HR, Eisenman RN et al. (2008) Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity. Cell Stem Cell3, 611624.
  • 72
    Pasi CE, Dereli-Oz A, Negrini S, Friedli M, Fragola G, Lombardo A, Van Houwe G, Naldini L, Casola S, Testa G et al. (2011) Genomic instability in induced stem cells. Cell Death Differ18, 745753.
  • 73
    Cheng L, Lloyd RV, Weaver AL, Pisansky TM, Cheville JC, Ramnani DM, Leibovich BC, Blute ML, Zincke H & Bostwick DG (2000) The cell cycle inhibitors p21WAF1 and p27KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapy. Clin Cancer Res6, 18961899.
  • 74
    Rossi DJ, Bryder D, Seita J, Nussenzweig A, Hoeijmakers J & Weissman IL (2007) Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature447, 725729.
  • 75
    Shepherd BE, Kiem HP, Lansdorp PM, Dunbar CE, Aubert G, LaRochelle A, Seggewiss R, Guttorp P & Abkowitz JL (2007) Hematopoietic stem-cell behavior in nonhuman primates. Blood110, 18061813.
  • 76
    Trumpp A, Essers M & Wilson A (2010) Awakening dormant haematopoietic stem cells. Nat Rev Immunol10, 201209.
  • 77
    Kippin TE, Martens DJ & van der Kooy D (2005) p21 loss compromises the relative quiescence of forebrain stem cell proliferation leading to exhaustion of their proliferation capacity. Genes Dev19, 756767.
  • 78
    Viale A, De Franco F, Orleth A, Cambiaghi V, Giuliani V, Bossi D, Ronchini C, Ronzoni S, Muradore I, Monestiroli S et al. (2009) Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells. Nature457, 5156.
  • 79
    Bonizzi G, Cicalese A, Insinga A & Pelicci PG (2012) The emerging role of p53 in stem cells. Trends Mol Med18, 612.
  • 80
    Seita J, Rossi DJ & Weissman IL (2010) Differential DNA damage response in stem and progenitor cells. Cell Stem Cell7, 145147.
  • 81
    Yamazaki S, Iwama A, Takayanagi S, Morita Y, Eto K, Ema H & Nakauchi H (2006) Cytokine signals modulated via lipid rafts mimic niche signals and induce hibernation in hematopoietic stem cells. EMBO J25, 35153523.
  • 82
    Tothova Z, Kollipara R, Huntly BJ, Lee BH, Castrillon DH, Cullen DE, McDowell EP, Lazo-Kallanian S, Williams IR, Sears C et al. (2007) FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell128, 325339.
  • 83
    Mohrin M, Bourke E, Alexander D, Warr MR, Barry-Holson K, Le Beau MM, Morrison CG & Passegue E (2010) Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis. Cell Stem Cell7, 174185.
  • 84
    Sotiropoulou PA, Candi A, Mascre G, De Clercq S, Youssef KK, Lapouge G, Dahl E, Semeraro C, Denecker G, Marine JC et al. (2010) Bcl-2 and accelerated DNA repair mediates resistance of hair follicle bulge stem cells to DNA-damage-induced cell death. Nat Cell Biol12, 572582.
  • 85
    Woodward WA, Chen MS, Behbod F, Alfaro MP, Buchholz TA & Rosen JM (2007) WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci USA104, 618623.
  • 86
    Blanpain C, Mohrin M, Sotiropoulou PA & Passegue E (2011) DNA-damage response in tissue-specific and cancer stem cells. Cell Stem Cell8, 1629.
  • 87
    Lane AA & Scadden DT (2010) Stem cells and DNA damage: persist or perish?Cell142, 360362.
  • 88
    Ishikawa K, Ishii H & Saito T (2006) DNA damage-dependent cell cycle checkpoints and genomic stability. DNA Cell Biol25, 406411.
  • 89
    Larsson LG (2011) Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence. Semin Cancer Biol21, 367376.
  • 90
    Serrano M, Lin AW, McCurrach ME, Beach D & Lowe SW (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell88, 593602.
  • 91
    Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C et al. (2005) DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature434, 864870.
  • 92
    Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B, Stein H, Dorken B, Jenuwein T & Schmitt CA (2005) Oncogene-induced senescence as an initial barrier in lymphoma development. Nature436, 660665.
  • 93
    Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W et al. (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature436, 725730.
  • 94
    Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, Benguria A, Zaballos A, Flores JM, Barbacid M et al. (2005) Tumour biology: senescence in premalignant tumours. Nature436, 642.
  • 95
    Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditullio RA Jr, Kastrinakis NG, Levy B et al. (2005) Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature434, 907913.
  • 96
    Lazzerini Denchi E, Attwooll C, Pasini D & Helin K (2005) Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland. Mol Cell Biol25, 26602672.
  • 97
    Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM, Majoor DM, Shay JW, Mooi WJ & Peeper DS (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature436, 720724.
  • 98
    Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, Schurra C, Garre M, Nuciforo PG, Bensimon A et al. (2006) Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature444, 638642.
  • 99
    Dankort D, Filenova E, Collado M, Serrano M, Jones K & McMahon M (2007) A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors. Genes Dev21, 379384.
  • 100
    Rube CE, Fricke A, Widmann TA, Furst T, Madry H, Pfreundschuh M & Rube C (2011) Accumulation of DNA damage in hematopoietic stem and progenitor cells during human aging. PLoS One6, e17487.
  • 101
    Stratton MR, Campbell PJ & Futreal PA (2009) The cancer genome. Nature458, 719724.
  • 102
    Kakarala M & Wicha MS (2008) Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. J Clin Oncol26, 28132820.
  • 103
    Clayton S & Mousa SA (2011) Therapeutics formulated to target cancer stem cells: is it in our future?Cancer Cell Int11, 7.
  • 104
    Leiva M, Moretti S, Soilihi H, Pallavicini I, Peres L, Mercurio C, Dal Zuffo R, Minucci S & de The H (2012) Valproic acid induces differentiation and transient tumor regression, but spares leukemia-initiating activity in mouse models of APL. Leukemia26, 16301637.
  • 105
    Bug G, Gul H, Schwarz K, Pfeifer H, Kampfmann M, Zheng X, Beissert T, Boehrer S, Hoelzer D, Ottmann OG et al. (2005) Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells. Cancer Res65, 25372541.
  • 106
    Kuendgen A, Strupp C, Aivado M, Bernhardt A, Hildebrandt B, Haas R, Germing U & Gattermann N (2004) Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid. Blood104, 12661269.
  • 107
    Trumpp A & Wiestler OD (2008) Mechanisms of Disease: cancer stem cells – targeting the evil twin. Nat Clin Pract Oncol5, 337347.
  • 108
    Essers MA, Offner S, Blanco-Bose WE, Waibler Z, Kalinke U, Duchosal MA & Trumpp A (2009) IFNalpha activates dormant haematopoietic stem cells in vivo. Nature458, 904908.
  • 109
    Lowenberg B, van Putten W, Theobald M, Gmur J, Verdonck L, Sonneveld P, Fey M, Schouten H, de Greef G, Ferrant A et al. (2003) Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia. N Engl J Med349, 743752.
  • 110
    Anguille S, Lion E, Willemen Y, Van Tendeloo VF, Berneman ZN & Smits EL (2011) Interferon-alpha in acute myeloid leukemia: an old drug revisited. Leukemia25, 739748.
  • 111
    Zuber J, Shi J, Wang E, Rappaport AR, Herrmann H, Sison EA, Magoon D, Qi J, Blatt K, Wunderlich M et al. (2011) RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature478, 524528.
  • 112
    Ito T, Kwon HY, Zimdahl B, Congdon KL, Blum J, Lento WE, Zhao C, Lagoo A, Gerrard G, Foroni L et al. (2010) Regulation of myeloid leukaemia by the cell-fate determinant Musashi. Nature466, 765768.
  • 113
    Naka K, Hoshii T, Muraguchi T, Tadokoro Y, Ooshio T, Kondo Y, Nakao S, Motoyama N & Hirao A (2010) TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature463, 676680.
  • 114
    Zhao C, Blum J, Chen A, Kwon HY, Jung SH, Cook JM, Lagoo A & Reya T (2007) Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell12, 528541.
  • 115
    Pantel K & Alix-Panabieres C (2007) The clinical significance of circulating tumor cells. Nat Clin Pract Oncol4, 6263.
  • 116
    Aguirre-Ghiso JA (2007) Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer7, 834846.
  • 117
    Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, Welch JS, Ritchey JK, Young MA, Lamprecht T, McLellan MD et al. (2012) Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature481, 506510.